—
HALO Growth 100 · Sector S2

Longevity & Healthspan

GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.

Equal-weight — 1d —
Cap-weighted — 1d —
Momentum (drift) — 1d —
Constituents — in this sector

Composite Index — since inception (Dec 30, 2025)

Three weighting variants of the same constituent basket, rebased to 1,000 at inception. EW = ticker-equal-weight with quarterly drift. CW = cap-weighted (10% cap; below ten names the cap is infeasible, so the sub-index is equal weight by construction) with semi-annual rebalance. MW = drift-only (1/N at inception, market does the tilting between rebalances). Click a legend entry to toggle its line.

Constituents

Every HALO 100 constituent tagged into this sector. Click a column header to sort (best to worst). Click a row to open the stock detail page in a new tab.

Ticker Company Region Last 1d 1w 1m 3m 6m 1y CCY
REGNRegeneronNAM955.47+0.45%+5.65%+19.98%+18.55%+36.84%+40.50%USD
LLYEli LillyNAM1443.50+1.14%+6.61%+15.33%+22.00%+43.64%+42.27%USD
GXI.DEGerresheimerEUR31.08-1.52%-0.38%+8.29%+11.08%+15.88%+25.83%EUR
AMGNAmgenNAM465.67-0.30%+1.14%+7.29%+11.04%+42.71%+40.43%USD
VKTXViking TherapeuticsNAM29.22+5.95%+8.87%+6.76%-13.11%-3.47%-28.35%USD
NVONovo NordiskEUR41.63+2.41%+3.27%+6.14%-7.24%-6.95%-14.13%USD
VRTXVertex PharmaNAM538.60-0.74%-1.55%+5.87%+4.47%+23.26%+24.05%USD
ZEAL.COZealand PharmaEUR242.00+0.37%+3.91%+5.49%-22.34%-19.20%-44.46%DKK
NTRANateraNAM319.09-1.19%+2.71%-21.17%+1.56%+71.22%+52.31%USD
ILMNIlluminaNAM207.01-1.21%-2.87%-22.74%+7.18%+45.23%+69.71%USD

FAQ · from the current data · as of 2026-11-13

Longevity & Healthspan — data Q&A

What is the Longevity & Healthspan sub-index of the HALO 100?

10 constituents, listed across EUR, NAM, computed equal-weight, cap-weight and momentum-weight from the same basket and rebased to 1,000 at the index base date. Part of the HALO 100 — /indices/halo/.

Which Longevity & Healthspan constituents lead and lag over one month?

As of 2026-11-13: leading — Regeneron (REGN) +19.98%; Eli Lilly (LLY) +15.33%; Gerresheimer (GXI.DE) +8.29%. Lagging — Illumina (ILMN) -22.74%; Natera (NTRA) -21.17%; Zealand Pharma (ZEAL.CO) +5.49%. Returns are close-to-close in each name's trading currency.

Which Longevity & Healthspan names have done best over one year?

As of 2026-11-13: Illumina (ILMN) +69.71%; Natera (NTRA) +52.31%; Eli Lilly (LLY) +42.27%. Weakest: Zealand Pharma (ZEAL.CO) -44.46%; Viking Therapeutics (VKTX) -28.35%; Novo Nordisk (NVO) -14.13%.

How often does this sub-index update, and is it advice?

The worker recomputes the sub-index and every constituent's returns after each US close (prices converted to USD for the index level; per-name returns stay in local currency). This page is a data surface in an investment research diary — it describes constituents and returns, it recommends nothing.